“ Anna has a business background in Economics and Finance, with previous experience in investment banking. Since stepping into the Life Science industry 8 years ago, Anna was part of the first agency to distribute CRISPR technology to European customers, becoming a co-founder at BioXplor and being featured in Forbes as one of the "Women-led founders driving the future of HealthTech".”

“ Pavel is a highly skilled engineer with a passion for bioinformatics software development in genomics, proteomics and metabolomics. He has a background in MEng Computer Science from Riga Technical University and MSc Applied Bioinformatics from Cranfield University. He has particular expertise in biological data classification and recognition of machine learning approaches using GPGPU-based predictive modelling.”

“ PhD graduate in Medical Science, specializing in biomedical data analysis and paediatrics. Proficiency in Python and R languages. Experience in clinical trials focusing on the treatments of autoimmune diseases. Her academic achievements include authoring 45 medical articles and 4 books.”

“ Kostiantyn is a professional developer with extensive experience in web technologies and application development. He holds a degree in Computer Science from the Ukraine Institute of Economic and Information Technologies, specializing in Programming and Automation of Computer Systems. With over 15 years of experience, Kostiantyn has mastered modern web technologies and the most popular frameworks for building progressive and high-performance mobile and web applications.”

“ Health Innovation, Digital Health, Medical Devices, Clinical, Global Strategy, AI, Deeptech, Ethics, Digital Intelligence, Health Care in Metaverse & Nanoverse, Digital Biomarkers.”

“ Professor and Bioengineer in genetics and genomics from Universidad Católica de la Santísima Concepción, Chile. His research covers the study of transcription factors involved in the progression of solid tumours in leukaemia. His work was published in many top journals.”

“ A consulting Data Scientist with multi-industry experience in analytics, machine learning and management.”

“ David studied at Harvard and Berkeley universities and is a Medical Director with 20+ years of industry experience (Novartis and Gilead). David is leading drug development and clinical trials in the area of autoimmunity and cardiovascular therapeutics.”

“ Bill studied at Yale and UC Berkeley. His current role is as the Chief Technology Officer at the University of Berkeley. He is a leader in engineering, product management, emerging technology and an enterprise-wide digital transformation to expand the use of cloud computing across all lines of business and implement new energy-efficient infrastructure in support of key priorities for AI and data science research.”

“ A successful entrepreneur, management consultant, board member, advisor and seasoned senior executive in Biotechnology, Pharmaceuticals, Devices, Diagnostics and Spacecraft & Space Systems. Todd started and built innovative companies with market capitalization of >$2B, raised over $80M in capital, including $4.5M in grant funding and has multiple exits with strong return.”